A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
Neri S, Bertino G, Petralia A, Giancarlo C, Rizzotto A, Calvagno GS, Mauceri B, Abate G, Boemi P, Di Pino A, Ignaccolo L, Vadalà G, Misseri M, Maiorca D, Mastrosimone G, Judica A, Palermo F.
Neri S, et al. Among authors: palermo f.
J Clin Gastroenterol. 2010 Oct;44(9):e210-7. doi: 10.1097/MCG.0b013e3181d88af5.
J Clin Gastroenterol. 2010.
PMID: 20838237
Clinical Trial.